Is AML different from CML in the accelerated phase?
AML and CML in the accelerated phase are different conditions, though they can look similar. Here are the key differences:
How they develop
- AML is a rapidly progressing leukemia that starts in the bone marrow and quickly spreads to the blood
- CML is a slowly Show Full Answer
Is AML different from CML in the accelerated phase?
AML and CML in the accelerated phase are different conditions, though they can look similar. Here are the key differences:
How they develop:
- AML is a rapidly progressing leukemia that starts in the bone marrow and quickly spreads to the blood
- CML is a slowly progressing cancer that goes through three phases: chronic, accelerated, and blast. The accelerated phase is when immature white blood cells (blasts) begin to increase
Genetic differences:
- AML commonly involves mutations in genes like FLT3, c-KIT, RAS, IDH1, IDH2, and TP53
- CML nearly always involves the Philadelphia chromosome, which creates a fusion gene called BCR-ABL that drives uncontrolled cell growth
Treatment approaches:
- AML is most commonly treated with chemotherapy
- CML is most commonly treated with drugs that target tyrosine kinase (the protein produced by the BCR-ABL gene)
Important note: CML in the blast phase (the most advanced stage) can look very similar to AML and may even be mistaken for it. However, they still differ in their underlying genetics and how they respond to treatment.
Understanding which condition you have is crucial for determining the most effective treatment plan.
March 9
Join
Your Privacy Choices
